Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $50 at H.C. Wainwright

October 24, 2022 6:34 AM EDT Send to a Friend
H.C. Wainwright analyst Andrew Fein raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $50.00 (from $35.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login